Is this the end of the road for tesla bulls?

Could board’s hand be forced to ask entrepreneur to stand down?

Following a trip in May to a US investment conference to meet with company bosses, James Harries, the manager of STS Global Trust, reported that, “as ever one cannot fail to be impressed by the sheer

Investors have a lot to think about as the president’s policies gather momentum

When a president uses his office to launch a cryptocurrency, it is clear that his modus operandi is to part people from their money. Apply this analysis to the global stage, tune out the furore over h

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Reaction suggests investors may no longer swayed by earnings ‘beats’